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Abstract
Objectives
Vascular calcification is a frequent complication in chronic haemodialysis patients and is
associated with adverse outcomes. Serum calcium and phosphate levels and imbalances in
calcification regulators are thought to contribute to the process. In this regard, the dialysate
calcium concentration is a modifiable tool for modulating the risk of vascular calcification.
We explored pre- and post-dialysis phosphate and calcium concentrations in stable chronic
haemodialysis patients treated by dialysis with the KDIGO-suggested 1.5 mmol/L calcium
dialysate to investigate the effects on ex vivo calcification of rat aortic rings.
Approach and results
At the end of haemodialysis, mean serum calcium levels were increased in 88% of paired
pre-/post-dialysis samples, while mean serum phosphate and parathyroid hormone levels
were decreased. Rat aortic ring cultures grown at the same calcium and phosphate concen-
trations revealed that pre- and post-dialysis resulted in a similar degree of calcification. By
contrast, haemodialysis with unchanged serum calcium resulted in a 5-fold reduction in cal-
cium deposition.
Conclusion
Dialysis with the widely prescribed 1.5 mmol/L calcium dose results in persistent high serum
calcification potential in a sizable proportion of patients, driven by increased post-dialysis
calcium concentration. This could potentially be mitigated by individualising dialysate cal-
cium dosage based on pre-dialysis serum calcium levels.
Introduction
Ectopic calcification of blood vessels, also known as vascular calcification, is among the most
common complications in patients receiving chronic haemodialysis, and is associated with
cardiovascular events and all-cause mortality [1,2]. Elevated serum phosphate is a predictable
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feature of chronic haemodialysis patients in the absence of dietary phosphate restrictions or
supplemental phosphate binders, and contributes to the substantial morbidity and mortality
rates in this population [2–4]. Accumulation of calcium-phosphate crystals in the aortic wall
is the main hallmark of vascular calcification. Incremental increases in the phosphate concen-
tration increase calcium-phosphate crystal formation [5] by shifting the H2PO4
-/HPO4
2- equi-
librium to the right [6], which promotes the association of HPO4
2- with calcium to form
brushite (CaHPO42H2O), octacalcium phosphate (Ca8H2(PO4)65H2O) and hydroxyapatite
(Ca10(PO4)6(OH)), the main crystal forms in ectopic calcification and bone.
The calcium-phosphate product (CaxPi) is also associated with an increased risk of vascular
calcification; however, the mortality risk associated with CaxPi levels is similar to that of phos-
phate alone [3,4], and this product is not a determinant of vascular calcification [5,7]. The cal-
cium concentration is a greater determinant of calcium-phosphate crystal formation than the
phosphate concentration [5]. For example, calcification may not be induced by elevated phos-
phate concentration when the calcium concentration is low [5]. Therefore, even if phosphate
is eliminated during dialysis, calcification can still occur provided that the calcium concentra-
tion is increased.
Since the dialysate calcium concentration is a modifiable factor that determines whether
serum calcium levels increase during haemodialysis, in the present study we analysed the
effects of calcium and phosphate concentrations during haemodialysis on the deposition of
calcium-phosphate crystals in the rat aortic wall.
Materials and methods
Haemodialysis conditions and sampling
All patients (from University Hospital Fundacio´n Jime´nez Dı´az, n = 68) received a conven-
tional purely diffusive 4 h (mid-week) haemodialysis session without haemodiafiltration using
a high-flux helixone dialyser (Fresenius; CUF, 59 ml/h/mmHg; surface, 1.8 m2). The dialysate
composition was 1.5 mmol/L calcium, 35 mmol/L bicarbonate, 0.75 mmol/L potassium, 0.5
mmol/L magnesium and 140 mmol/L sodium. Thus, the dialysate calcium concentration was
within the lower range of the Kidney Disease: Improving Global Outcomes (KDIGO) Chronic
Kidney Disease-Mineral and Bone Disorder (CKD-MBD) guidelines of 1.25–1.50 mmol/L [8].
The main clinical characteristics of patients are summarised in Table 1.
Pre- and post-haemodialysis blood samples were collected in heparin-containing tubes and
immediately centrifuged at 4˚C for 5 min at 5000 rpm. Plasma samples were frozen in liquid
nitrogen and stored at -80˚C until further use. In 24 patients, phosphate levels were measured
Table 1. Demographic and clinical characteristics of the study population. Data expressed as mean
±SD or %.
Age (years) 65.3 ± 14.9
Dry weight (Kg) 66.1 ± 12.2
Dialysis vintage (years) 4.3 ± 4.3
Males (%) 51.5
Kt / v urea 1.47 ± 0.3
*Vitamin D therapy (%) 55.9
Cinacalcet (%) 19.1
Calcium-based phosphate binders (%) 42.6
Sevelamer (%) 36.7
*25OH vitamin D, calcitriol or paricalcitol.
https://doi.org/10.1371/journal.pone.0183730.t001
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in two independent extractions at each time point. This study was conducted according to the
Declaration of Helsinki and approved by the Ethics Committee of Research of University Hos-
pital Fundacio´n Jime´nez Dı´az. Participants were identified by number only. Inclusion criteria
stipulated that only consenting stable adults on chronic haemodialysis with a life expectancy of
over 6 months were included. There were no excluding criteria based on compliance, calcium,
phosphate, parathyroid hormone (PTH) or vitamin D levels, or concomitant medications.
Patients with positive serology for human immunodeficiency virus (HIV), hepatitis B surface
antigen (HBsAg) or anti-hepatitis virus (HVC) antibodies or other known active infection
were excluded.
Animals
Male Sprague-Dawley rats (body weight, 200–400 g) were obtained from Charles River Labo-
ratories (Barcelona, Spain). The protocol was approved by the Fundacio´n Jime´nez Dı´az
(FIIS-FJD) ethics committee and conformed to directive 2010/63EU and recommendation
2007/526/EC regarding the protection of animals used for experimental and other scientific
purposes, enforced in Spanish law under RD1201/2005.
Aorta isolation and calcification assay
Rats were euthanised by carbon dioxide inhalation, and aortas were perfused with saline and
removed according to previous descriptions [9,10] and frozen immediately. Four or five rings
were obtained from each aorta (n = 24) and cultured ex vivo (37˚C, in a humidified atmo-
sphere of 5% CO2) in 6-well culture plates using Minimum Essential Medium (MEM; Gibco,
Paisley, UK) containing 1 mM L-glutamine, 100 IU/mL penicillin, 100 μg/mL streptomycin
and the indicated calcium and phosphate concentration, as previously described [5]. The
medium was replaced every 2 days and contained 45calcium (Perkin Elmer; Boston, USA) as a
radiotracer. After 6 days of incubation, aortic rings were dried and weighed, and radioactivity
was measured using liquid scintillation (Ultima Gold, 6013329, Perkin Elmer) and a liquid
scintillation counter (Tri-Carb 2900TR, Perkin Elmer).
Biochemical assessments
Calcium, ionized calcium and intact PTH levels in plasma were quantified by routine clinical
biochemistry laboratory methods. For phosphate quantification, the Phosphate Assay Kit
(MAK030-1KT, Sigma-Aldrich) was used according to the manufacturer’s instructions.
Statistical analyses
Results in Figs 1, 2, 3 and Table 1 are presented as mean and standard deviation (SD) or
median (interquartile range). The Wilcoxon matched pairs test was used for statistical analysis
of results presented in Figs 1A and 2. The Mann-Whitney test was used in Fig 1C. One-way
ANOVA and Tukey’s multicomparison test were used in Fig 3. Statistical significance was
determined with GraphPad Prism 5 and was assigned at p< 0.05.
Results
Plasma calcium levels (n = 68) were significantly increased by 14.3% (p< 0.001) post-haemo-
dialysis (2.4 ± 0.2 mmol/L) compared with pre-haemodialysis (2.1 ± 0.2 mmol/L) values.
Serum calcium was increased in 88.2% (60/68) of the paired pre-/post-dialysis samples ana-
lysed (Fig 1A, S1 Table). Changes in the PTH level during haemodialysis were correlated with
Serum calcium levels and vascular calcification
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changes in calcium levels. Fig 1B shows a significant correlation (R2 = 0.2; p< 0.001) between
post- and pre-haemodialysis calcium level differences (ΔCalcium) and post- and pre-haemo-
dialysis PTH level differences (ΔPTH). Thus, PTH levels were increased during haemodialysis
(median (IQR) = 1 (-102.1; 113.7) pg/mL; n = 10) when ΔCalcium was0 mmol/L; (Fig 1C
Fig 1. Calcium and PTH concentration in haemodialysis patients. (A) Plasma calcium concentration in pre- and post-haemodialysis samples
(n = 68). The Wilcoxon matched pairs test was used for statistical analysis. (B) Scatter graph displaying a significant (p < 0.001) correlation between
ΔCalcium (ΔCa, the difference between post- and pre-haemodialysis calcium concentration) and ΔPTH (the difference between post- and pre-
haemodialysis PTH concentration). (C) ΔPTH based on ΔCalcium (ΔCa0 or ΔCa >0 mmol/L). The Mann-Whitney test was used for statistical
analysis. **p < 0.01; ***p < 0.001. PreHD, pre-haemodialysis; PostHD, post-haemodialysis.
https://doi.org/10.1371/journal.pone.0183730.g001
Fig 2. Inorganic phosphate and ionized calcium concentration in haemodialysis patients. (A) Plasma phosphate concentration in pre-
and post-haemodialysis samples (n = 92). (B) Plasma ionized calcium concentration in pre- and post-haemodialysis samples (n = 45). The
Wilcoxon matched pairs test (pre- versus post-haemodialysis) was used for statistical analysis. ***p < 0.001. PreHD, pre-haemodialysis;
PostHD, post-haemodialysis.
https://doi.org/10.1371/journal.pone.0183730.g002
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ΔCa0). By contrast, PTH levels were significantly decreased (p = 0.007; median (IQR) =
-160.2 (-300.1; -43.6) pg/mL; n = 58) when ΔCalcium was>0 mmol/L (Fig 1C ΔCa>0).
Plasma phosphate levels were significantly decreased by 32.0% (p< 0.001) post-haemodia-
lysis versus pre-haemodialysis (2.5 ± 0.6 vs. 1.7 ± 0.4 mmol/L, respectively; Fig 2A). Pre-hae-
modialysis phosphate levels ranged from 1.05 to 3.89 mmol/L, and in 93.5% of cases they were
in the hyperphosphatemia range (>1.5 mmol/L phosphate). A decrease in the phosphate level
post-haemodialysis was observed in all paired samples analysed (n = 92). Interestingly, 69.6%
of post-haemodialysis plasma phosphate samples remained above 1.5 mmol/L phosphate, and
52.2% were above 1.7 mmol/L phosphate. In addition to plasma calcium levels, ionized cal-
cium levels (Fig 2B) were also significantly increased (p< 0.001) in post-haemodialysis plasma
(1.26 ± 0.09—mmol/L) versus pre-haemodialysis plasma (1.07 ± 0.09—mmol/L).
Finally, aortic rings were cultured in medium containing the same post-haemodialysis Ca
and Pi concentrations (2.4 mmol/L and 1.5 mmol/L, respectively) or pre-haemodialysis Ca
and Pi concentrations (2.1 mmol/L and 2.5 mmol/L, respectively) as those measured above,
and the results are shown in Fig 3 and S2 Table. No significant differences were observed in
calcium deposition on the aortic wall ex vivo (1654.5 ± 485.2 μmol/g and 1472.9 ± 472.1 μmol/
Fig 3. Calcium deposition in the rat aortic wall ex vivo under calcium and phosphate concentrations matching pre- and
post-haemodialysis levels in haemodialysis patients. Rat aortic rings were incubated ex vivo in MEM medium containing the
indicated concentrations of calcium and phosphate. The medium was replaced every 2 days and contained 45calcium as a
radiotracer. After 6 days of incubation, aortic rings were dried and radioactivity was measured by liquid scintillation counting. Results
are represented as mean ± SD from three independent experiments, with 15 or 16 rings per condition (five or six rings per condition
per experiment). One-way ANOVA and Tukey’s multicomparison test were used for statistical analysis. Calcium and phosphate
concentrations are in mmol/L. *p < 0.05; ***p < 0.001. Pre-dialysis conditions were used as a reference. PreHD, pre-
haemodialysis; PostHD, post-haemodialysis.
https://doi.org/10.1371/journal.pone.0183730.g003
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g, respectively; n = 15) between Ca and Pi concentrations measured pre- and post-dialysis.
By contrast, the amount of calcium deposited in the aortic wall was significantly lower
(900.6 ± 254.5 μmol/g; p< 0.01) when the calcium concentration was 2.1 mmol/L (as would
be expected in post-haemodialysis samples if the calcium level did not change during dialysis)
and the phosphate concentration was 1.5 mmol/L (as observed in post-haemodialysis
samples).
In addition, similar results were obtained when the ionized calcium concentration mea-
sured above (1.1 mmol/L and 1.3 mmol/L pre- and post-haemodialysis, respectively) was used.
In this case, a significant increase (p< 0.05; n = 16) in calcium deposited on the aortic wall
was observed under post-haemodialysis conditions (345.8 ± 72.3 μmol/g; 1.3 mmol/L calcium
and 1.5 mmol/L phosphate) compared with pre-dialysis conditions (270.5 ± 66.4 μmol/g; 1.1
mmol/L calcium and 2.5 mmol/L phosphate). By contrast, the amount of calcium deposited in
the aortic wall was significantly lower (83.9 ± 16.1 μmol/g; p< 0.001) when the calcium con-
centration was 1.1 mmol/L and the phosphate concentration was 1.5 mmol/L (Fig 3).
Discussion
In biological systems, phosphorus is found in hard tissues (mainly bone, 85%), soft tissues
(14%) and extracellular fluid (1%). Of the 1% that is present in extracellular fluid, 85% exists as
the free inorganic phosphate ion (Pi) in solution. The normal range for plasma inorganic phos-
phate is 0.8–1.5 mmol/L. An elevated phosphate level is a risk factor for vascular calcification,
cardiovascular disease and mortality [3,4]; therefore, phosphate is considered a uremic toxin
that needs to be eliminated during haemodialysis. In this study, we observed a reduction in the
plasma phosphate concentration during haemodialysis, from 2.5 mmol/L (pre-dialysis) to 1.7
mmol/L (post-dialysis). However, ~70% of post-haemodialysis samples remained above 1.5
mmol/L. By contrast, the calcium concentration was higher in post-dialysis plasma in 88% of
paired samples analysed (2.1 vs. 2.4 mmol/L for mean pre- and post-dialysis plasma calcium
concentrations, respectively). Under these pre- and post-haemodialysis levels of calcium and
phosphate, calcium accumulation in the aortic wall was similar. Thus, a conventional haemo-
dialysis session, using a fixed and non-individualised dialysate calcium dosage within the
range suggested by international guidelines [8] did not improve the vascular calcification risk
associated with calcium and phosphate concentrations found in serum. By contrast, a signifi-
cant reduction in calcium accumulation in the rat aortic wall was observed when mimicking
post-haemodialysis conditions associated with neutral post-dialysis calcium levels. This
assumes that post-haemodialysis calcium remained unchanged during the haemodialysis ses-
sion (2.1 mmol/L calcium and 1.5 mmol/L phosphate). Similar results were also observed
when ionized calcium levels were used.
Post-dialysis calcium levels depend on pre-dialysis plasma calcium, dialysate calcium and
ultrafiltration. Lower post-dialysis ionised calcium levels are associated with an increase in
serum PTH levels, while an increase in post-dialysis ionised calcium results in suppression of
PTH, as observed both in the present study and previously [11,12]. While we did not perform
detailed ionised calcium balance studies, the observed suppression of serum PTH in patients
in whom serum calcium increased during dialysis suggests that the observed increase in serum
calcium was physiologically relevant. In this regard, increased calcium levels are associated
with the maintenance of a similar procalcific effect ex vivo, despite the reduction in the phos-
phate concentration, as shown here. Thus, the present findings support the concept of perso-
nalisation of dialysate calcium based on individual patient pre-dialysis serum calcium to
maintain balanced calcium levels. The current KDIGO CKD-MBD guidelines also emphasise
the concept of individualisation of dialysate calcium [8]. Our findings suggest that dialysate
Serum calcium levels and vascular calcification
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calcium of 1.5 mmol/L results in a persistent post-dialysis risk of vascular calcification in a siz-
able proportion of patients, and further individualisation would be desirable. Moreover, Ok
et al, observed a reduction in the progression of coronary artery calcification when the dialy-
sate calcium level was 1.25 mmol/L, supporting the notion that lowering dialysate calcium
would be effective in preventing progression of vascular calcification [13]. However, if the dial-
ysate calcium concentration is too low, this could result in haemodynamic instability and
arrhythmia, hence the need for dialysate calcium individualisation.
Among the weaknesses of the present study, in the rat aortic ring culture conditions, we did
not model the increase in pH and serum bicarbonate associated with the haemodialysis proce-
dure, which could affect the positive base balance and cause metabolic alkalosis [14,15]. Given
that metabolic alkalosis, or even the correction of acidosis, is associated with increased vascular
calcification risk under uremic conditions [16–19], our approach may have underestimated
the procalcification effect of post-haemodialysis calcium and phosphate concentrations. For
example, Villa-Bellosta et al. observed an increase in calcium-phosphate deposition at alkaline
pH in an in vitro calcification model, while no calcium-phosphate deposition was observed
under acidosis conditions [5]. Moreover, post-dialysis alkalinisation results in increased alka-
line phosphatase activity [20]. This consequently lowers the availability of pyrophosphate, the
main endogenous inhibitor of calcium-phosphate crystal formation and growth. Finally, our
experiments did not model the dynamic nature of the calcium concentration during the 48 h
between haemodialysis sessions. However, haemodialysis patients may experience repeated
(thrice weekly) serum calcium peaks over many years (decades in countries with low trans-
plantation rates), which, combined with evidence of positive calcium balance in a significant
number of patients during haemodialysis [21], supports the clinical relevance of the findings.
In conclusion, the present findings suggest that the frequent current practice of using a
one-size-fits-all dialysate calcium concentration may result in the persistence of calcification-
prone serum calcium and phosphate concentrations post-dialysis, and support the concept of
dialysate calcium concentration individualisation. While the international guidelines already
propose the individualisation of the dialysate calcium concentration, the suggested default cal-
cium dialysate value may still be too high and might promote vascular calcification in a sizable
proportion of patients [8].
Supporting information
S1 Table. Experimental results Fig 1.
(PDF)
S2 Table. Experimental results Fig 3.
(PDF)
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